Industry | 2019.11.06
Former Vice President and Global Head of Quantitative Clinical Pharmacology at AstraZeneca Joins NDA Partners
NDA Partners Chairman Carl Peck, MD, announced today that Donald Stanski, MD, a senior pharmaceutical industry executive and expert in clinical pharmacology and pharmacometrics has joined the firm as an Expert Consultant. Dr. Stanski is widely recognized for his expertise in applying systems pharmacology modeling and simulation and advanced statistical analytics with drug and disease models.
(PRWeb November 06, 2019)
Read the full story at https://www.prweb.com/releases/former_vice_president_and_global_head_of_quantitative_clinical_pharmacology_at_astrazeneca_joins_nda_partners/prweb16696979.htm
For more information, please visit
https://www.prweb.com/releases/former_vi[...]nda_partners/prweb16696979.htm
